ZLZhihao Li

Zhihao Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zhihao Li has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Chi Zhang

    Department of General Surgery The Sixth Affiliated Hospital, Sun Yat‐sen University Guangzhou Guangdong China

    1 shared publication
  • Haoxian Ke

    Department of General Surgery The Sixth Affiliated Hospital, Sun Yat‐sen University Guangzhou Guangdong China

    1 shared publication
  • Jiawei Cai

    Department of General Surgery The Sixth Affiliated Hospital, Sun Yat‐sen University Guangzhou Guangdong China

    1 shared publication
  • Junfeng Huang

    Department of General Surgery The Sixth Affiliated Hospital, Sun Yat‐sen University Guangzhou Guangdong China

    1 shared publication
  • Ming Yuan

    Department of General Surgery (Colorectal Surgery) The Sixth Affiliated Hospital Sun Yat‐sen University Guangzhou Guangdong 510655 China

    1 shared publication
  • Ping Lan

    Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    1 shared publication

Latest Publications

  • Open Access

    MTHFD1 Regulates Autophagy to Promote Growth and Metastasis in Colorectal Cancer via the PI3K‐AKT–mTOR Signaling Pathway

    by Zhihao Li, Haoxian Ke, Jiawei Cai, Shubiao Ye, Junfeng Huang, Chi Zhang, Ming Yuan, Ping Lan, Xianrui Wu

    Objectives: Methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) is the enzyme with the activities of methylenetetrahydrofolate dehydrogenase, methylenetetrahydrofolate cyclohydrolase, and formyltetrahydrofolate synthetase. Our aim was to elucidate the function of MTHFD1 in colorectal cancer (CRC).Methods: In vitro assessments of the proliferation, invasion, and migration abilities of CRC cells were conducted using Immunohistochemistry, Transwell invasion assays, Western blot (WB), and Cell counting Kit‐8 assays. WB was also utilized to measure autophagy protein levels and PI3K‐AKT‐mTOR signaling pathway expression. Furthermore, the role of MTHFD1 was evaluated in vivo by using subcutaneous xenograft tumor models and lateral tail vein metastasis models of human CRC in nude mice.Results: Overexpression of MTHFD1 promoted the abilities of tumorigenesis and metastasis in CRC in vitro and in vivo and reduced autophagy, attributing to the PI3K‐AKT‐mTOR signaling pathway in CRC cells. In contrast, the down‐regulation of MTHFD1 increased autophagy and suppressed their proliferation, migration, and invasion.Conclusions: MTHFD1 can modulate the PI3K‐AKT‐mTOR signaling pathway to suppress autophagy and stimulate tumorigenesis and metastasis.